Arbutus Biopharma Corp (NASDAQ:ABUS)

3.07
Delayed Data
As of Jan 17
 +0.02 / +0.66%
Today’s Change
0.82
Today|||52-Week Range
4.75
+10.43%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.05
Today’s open3.07
Day’s range3.01 - 3.10
Volume217,309
Average volume (3 months)610,448
Market cap$192.5M
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+22.17%
Earnings growth (this year)-90.74%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-44.44%
P/E ratioNM
Price/Sales35.63
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV+0.06+2.03%
OVIDOvid Therapeutics In...+0.06+1.54%
EYPTEyePoint Pharmaceuti...-0.01-0.58%
ARCTArcturus Therapeutic...-0.32-2.63%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateMarch 9, 2020
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$5.9M
Annual profit (last year)-$57.1M
Net profit margin-959.80%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Burnaby, British Columbia

Forecasts